Vicarious Surgical Inc (RBOT)
0.3814
-0.04
(-9.69%)
USD |
NYSE |
May 20, 16:00
0.38
0.00 (0.00%)
Pre-Market: 20:00
Vicarious Surgical Enterprise Value: -27.98M for May 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 20, 2024 | -27.98M |
| May 17, 2024 | -21.96M |
| May 16, 2024 | -35.53M |
| May 15, 2024 | -38.74M |
| May 14, 2024 | -35.60M |
| May 13, 2024 | -42.17M |
| May 10, 2024 | -41.43M |
| May 09, 2024 | -40.62M |
| May 08, 2024 | -39.62M |
| May 07, 2024 | -39.53M |
| May 06, 2024 | -39.81M |
| May 03, 2024 | -38.43M |
| May 02, 2024 | -39.76M |
| May 01, 2024 | -42.76M |
| April 30, 2024 | -42.82M |
| April 29, 2024 | -42.91M |
| April 26, 2024 | -44.38M |
| April 25, 2024 | -45.41M |
| April 24, 2024 | -43.95M |
| April 23, 2024 | -42.38M |
| April 22, 2024 | -44.17M |
| April 19, 2024 | -33.43M |
| April 18, 2024 | -35.04M |
| April 17, 2024 | -35.39M |
| April 16, 2024 | -32.56M |
| Date | Value |
|---|---|
| April 15, 2024 | -32.45M |
| April 12, 2024 | -29.02M |
| April 11, 2024 | -26.59M |
| April 10, 2024 | -26.73M |
| April 09, 2024 | -24.30M |
| April 08, 2024 | -31.73M |
| April 05, 2024 | -35.92M |
| April 04, 2024 | -39.79M |
| April 03, 2024 | -35.63M |
| April 02, 2024 | -35.60M |
| April 01, 2024 | -32.64M |
| March 28, 2024 | -45.19M |
| March 27, 2024 | -46.80M |
| March 26, 2024 | -41.80M |
| March 25, 2024 | -39.32M |
| March 22, 2024 | -38.11M |
| March 21, 2024 | -31.39M |
| March 20, 2024 | -37.53M |
| March 19, 2024 | -36.77M |
| March 18, 2024 | -32.97M |
| March 15, 2024 | -30.92M |
| March 14, 2024 | -40.79M |
| March 13, 2024 | -37.51M |
| March 12, 2024 | -39.56M |
| March 11, 2024 | -37.53M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-71.66M
Minimum
Nov 14 2023
1.739B
Maximum
Sep 24 2021
312.64M
Average
217.08M
Median
Mar 06 2023
Enterprise Value Benchmarks
| Ekso Bionics Holdings Inc | 20.67M |
| Perspective Therapeutics Inc | 835.95M |
| Xtant Medical Holdings Inc | 116.96M |
| Asensus Surgical Inc | 60.09M |
| Catheter Precision Inc | 2.901M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.00M |
| Total Expenses (Quarterly) | 16.11M |
| EPS Diluted (Quarterly) | -0.10 |
| Earnings Yield | -99.63% |